Latest update May 13th, 2024 12:59 AM
Sep 17, 2020 News
Minister of Health, Dr. Frank Anthony, has announced that government will be able to acquire Remdesivir at a reduced cost. The drug is one that has been approved to treat COVID-19.
The announcement to procure the drug comes even as plans are in train to purchase the drug to treat critically ill patients with sums allocated for drug purchases in the 2020 Budget.
Remdesivir is an anti-viral drug administered by Intravenous (IV) Therapy to COVID-19 patients suffering from severe symptoms. It is known as a nucleoside analogue, which means that it mimics a component of viral Ribonucleic acid (RNA) that the virus needs to replicate itself.
“Remdesivir is a very costly drug that is used in the US for the treatment of COVID-19 patients. We have been able to acquire this medicine out of India and the company that is manufacturing this particular drug was licensed by GILEAD to be able to produce this generic version,” Minister Anthony said.
Early international clinical trial results for the drug indicated a quicker recovery period, from 15 days to 11 days. This has earned the drug an Emergency Use Authorization (EUA) from the Food and Drug Administration in the US, allowing it to be used more widely outside of clinical trials.
The Minister explained that the drug is being made available to Guyana at a cheaper cost and has already been used to treat hospitalised and critically ill COVID-19 patients. Guyana had initially received 240 doses of the drug.
Minister Anthony also alluded to the fact that the drug was never listed on the Ministry’s inventory as it was not available for purchase on the international market.
The Minister added that the goal is to ensure that adequate doses are available as it can significantly reduce COVID-19 deaths.
Listen how to run an oil country
May 13, 2024
GCB T10 Blast Semi-finals… Kaieteur Sports – The semi-finals of the GCB T10 Blast will get underway today, barring inclement weather as the final four teams look to book spots in the...Kaieteur News – The PPP is engaging in myth-making in seeking to perpetuate the narrative that it is now an ideologically... more
By Sir Ronald Sanders Is it ever justifiable for journalism to fan the flames of geopolitical tension? This question arises... more
Freedom of speech is our core value at Kaieteur News. If the letter/e-mail you sent was not published, and you believe that its contents were not libellous, let us know, please contact us by phone or email.
Feel free to send us your comments and/or criticisms.
Contact: 624-6456; 225-8452; 225-8458; 225-8463; 225-8465; 225-8473 or 225-8491.
Or by Email: [email protected] / [email protected]